ZRSEF Zur Rose Group AG

USD 95.77 0.00 0
Icon

Zur Rose Group AG (ZRSEF) Stock Analysis and Price Targets

COMMON STOCK | Pharmaceutical Retailers | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 95.77

0.00 (0.00)%

USD 1.11B

N/A

N/A

N/A

Icon

ZRSEF

Zur Rose Group AG (USD)
COMMON STOCK | OTC
USD 95.77
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.11B

N/A

USD 95.77

Zur Rose Group AG (ZRSEF) Stock Forecast

N/A

Based on the Zur Rose Group AG stock forecast from 0 analysts, the average analyst target price for Zur Rose Group AG is not available over the next 12 months. Zur Rose Group AG’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Zur Rose Group AG is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Zur Rose Group AG’s stock price was USD 95.77. Zur Rose Group AG’s stock price has changed by +0.00% over the past week, +8.09% over the past month and +253.92% over the last year.

No recent analyst target price found for Zur Rose Group AG
No recent average analyst rating found for Zur Rose Group AG

Company Overview Zur Rose Group AG

DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers prescription and over-the-counter medicines, consumer health products, beauty and personal care products, nutritiona...Read More

Walzmühlestrasse 49, Frauenfeld, Switzerland, 8500

0

December

USD

USA

Adjusted Closing Price for Zur Rose Group AG (ZRSEF)

Loading...

Unadjusted Closing Price for Zur Rose Group AG (ZRSEF)

Loading...

Share Trading Volume for Zur Rose Group AG Shares

Loading...

Compare Performance of Zur Rose Group AG Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ZRSEF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Zur Rose Group AG (Sector: Pharmaceutical Retailers )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
RADLY
Raia Drogasil SA ADR -0.47 (-8.58%) USD8.58B 41.67 3.76

ETFs Containing ZRSEF

Symbol Name ZRSEF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Zur Rose Group AG (ZRSEF) Stock

Stock Target Advisor's fundamental analysis for Zur Rose Group AG's stock is Slightly Bearish.

Unfortunately we do not have enough data on ZRSEF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on ZRSEF's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on ZRSEF's stock to indicate if its overvalued.

The last closing price of ZRSEF's stock was USD 95.77.

The most recent market capitalization for ZRSEF is USD 1.11B.

Unfortunately we do not have enough analyst data on ZRSEF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Zur Rose Group AG's stock.

As per our most recent records Zur Rose Group AG has 0 Employees.

Zur Rose Group AG's registered address is Walzmühlestrasse 49, Frauenfeld, Switzerland, 8500. You can get more information about it from Zur Rose Group AG's website at https://corporate.docmorris.com/en.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...